Welcome to our dedicated page for Anterix SEC filings (Ticker: ATEX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Anterix Inc. (NASDAQ: ATEX) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures, including annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K. These filings detail how Anterix describes its business as a provider of private 900 MHz licensed spectrum and advanced intelligent infrastructure solutions for utilities and other critical infrastructure sectors.
In its periodic reports, Anterix presents financial statements and notes that cover spectrum revenue, gains on exchange and sale of spectrum-related intangible assets, investments in spectrum clearing, deferred revenue, contingent liabilities, cash and cash equivalents, and other key balance sheet and income statement items. Investors can review these documents to understand the company’s spectrum assets, contracted proceeds from customers, and pipeline of prospective contract opportunities.
Current reports on Form 8-K for Anterix include disclosures about quarterly and annual financial results, leadership changes such as the appointment or resignation of executive officers, shareholder meeting outcomes, and changes in the company’s independent registered public accounting firm. These filings provide timely information about significant corporate events and governance matters.
On Stock Titan, Anterix filings are accompanied by AI-powered summaries that highlight the main points of lengthy documents, helping users quickly identify items such as revenue drivers, spectrum transactions, and notable risk factors. Real-time updates from the SEC’s EDGAR system ensure that new 10-K, 10-Q, and 8-K filings, as well as other relevant forms, appear promptly. Users can also review insider-related disclosures when they are filed, gaining additional context on executive and director activity related to ATEX.
Anterix Inc (NASDAQ: ATEX) has filed its Annual Report (Form 10-K) for the fiscal year ended March 31, 2025. The company, headquartered in Woodland Park, New Jersey, operates as a smaller reporting company and non-accelerated filer.
Key Financial & Market Highlights:
- Market value of non-affiliate held stock: $417.57 million (as of September 30, 2024)
- Outstanding shares: 18,695,874 (as of June 18, 2025)
- Trading venue: Nasdaq Capital Market
Corporate Structure & Governance: The company is incorporated in Delaware and maintains principal executive offices in Woodland Park, NJ. The filing confirms Anterix is not a well-known seasoned issuer or shell company, and has maintained compliance with SEC filing requirements. The company will file its proxy statement for the 2025 Annual Meeting of Stockholders separately, which will contain additional governance information.
Anterix (NASDAQ: ATEX) filed an 8-K report announcing two key disclosures on June 24, 2025:
- Release of fiscal 2025 fourth quarter and year-end financial results for the period ended March 31, 2025
- Publication of an update to their Demonstrated Intent key performance indicator on the company's investor relations website
The filing indicates that both the earnings release and Demonstrated Intent Update are furnished as exhibits (99.1 and 99.2) rather than filed, meaning they are being provided for informational purposes but not formally incorporated into SEC filings. The report was signed by Timothy A. Gray, Chief Financial Officer. The company, headquartered in Woodland Park, NJ, trades on the Nasdaq Stock Market with common stock at $0.0001 par value.